# Indomethacin

## Indoy 25mg

| TAH Drug Code      | [OINDO2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OINDO2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Inflammation, pain in the musculoskeletal system, swelling after dental surgery                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Depending on the patient's response and tolerance, 25mg(1 capsule) twice or three times a day for adults, with or after meal.                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | 1. Disabled for active gastric ulcers; should also be used with caution in patients with past gastric ulcers. 2. Patients with asthma caused by allergic to Aspirin are banned. 3. Disabled for children under the age of fourteen; use caution for patients who are pregnant or breastfeeding. 4. Patients with epilepsy, Parkinson's disease and mental illness should also pay attention to use. 5. The drug was banned within 14 days after the Coronary artery bypass graft (CABG).                                                                                                                |
| Adverse Effects    | >10%:Headache (12% to 16%), Vomiting (<=12%), Postoperative hemorrhage (<=11%) 1% to 10%:Presyncope (<=3%), syncope (<=2%), Dizziness (3% to 9%), depression (1% to 3%), drowsiness (1% to 3%), fatigue (1% to 3%), malaise (1% to 3%), vertigo (1% to 3%), Pruritus (1% to 4%), hyperhidrosis (2%), skin rash (1% to 2%), Hot flash (2%), Epigastric pain (3% to 9%), heartburn (3% to 9%), nausea (3% to 9%), dyspepsia (2% to 9%), constipation (?6%), abdominal distress (1% to 3%), abdominal pain (<3%), diarrhea (<3%), decreased appetite (>=2%), Tinnitus (>1%), Swelling (3%; postprocedural) |
| Pregnancy          | Human Data Suggest Risk in 1st and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

